A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19
Abstract Background Past respiratory viral epidemics suggest that bacterial infections impact clinical outcomes. There is minimal information on potential co-pathogens in patients with coronavirus disease-2019 (COVID-19) in the US. We analyzed pathogens, antimicrobial use, and healthcare utilization...
Main Authors: | Laura Puzniak, Lyn Finelli, Kalvin C. Yu, Karri A. Bauer, Pamela Moise, Carisa De Anda, Latha Vankeepuram, Aryana Sepassi, Vikas Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-05877-3 |
Similar Items
-
Infection against infection: parasite antagonism against parasites, viruses and bacteria
by: Shi-Shi Shen, et al.
Published: (2019-06-01) -
Staphylococcus aureus Biofilm Growth on Cystic Fibrosis Airway Epithelial Cells Is Enhanced during Respiratory Syncytial Virus Coinfection
by: Megan R. Kiedrowski, et al.
Published: (2018-08-01) -
Leptospirosis and Coinfection: Should We Be Concerned?
by: Asmalia Md-Lasim, et al.
Published: (2021-09-01) -
Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?
by: Sharvan Sehrawat, et al.
Published: (2018-05-01) -
Porcine Respiratory Cell and Tissue Coinfections and Superinfections with Porcine Reproductive and Respiratory Syndrome and Swine Influenza Viruses
by: Georges Saade, et al.
Published: (2020-06-01)